Lattice Capital Management, LLC Mesoblast LTD Transaction History

Lattice Capital Management, LLC

  • $109 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 19, 2022
BUY
$4.17 - $7.09 $125,517 - $213,409
30,100 New
30,100 $144,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Lattice Capital Management, LLC Portfolio

Follow Lattice Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lattice Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lattice Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email